Based on prior understanding of mTOR pathway activity in other primary malignancies, the inclusion of hormone treatment was tested in a small case series of progressive PEComas following mTOR inhibitors and revealed an intriguing effectiveness signal. This evidence concerns the gene MTOR and neoplasm with perivascular epithelioid cell differentiation.